1.Two cases of emphysematous pyelonephritis
Jae Kyu KIM ; I Ho YOON ; Yng Ki CHUNG ; Byung Sik NAH ; Hyon De CHUNG
Journal of the Korean Radiological Society 1985;21(6):1012-1016
Emphysematous pyelonephritis is rare but freuently fatal complication of renal parenchymal infection, mostcommonly occurs in diabetic patients and is often associated with urinary obstruction, prior urologicalabnormality or infection. From 1898 to 1984 , about 50 cases of empysematous pyelonephritis have been reporteduniversally. The diaignosis of emphysematous pyelonephritis can be made only roentgenographically. In the last 2years, we have had two cases of emphysematous pyelonephritis at our hospital. It is our purpose to report twopatients who have survived wtih a brief review of the previous literature.
Humans
;
Pyelonephritis
2.Effects of Polyphosphate on the Fusion of Rabbit Lumbar Spine.
Journal of Korean Society of Spine Surgery 2004;11(1):1-13
STUDY DESIGN: Posterior and posterolateral fusions were performed in rabbit lumbar spines. OBJECTIVES: To investigate the osteoinductive effect of polyphosphates. SUMMARY AND LITERATURE REVIEW: Inorganic polyphosphates are known to be rich in osteoblasts and involved in the mineralization process in bone metabolism. However, no study has been undertaken to investigate the osteoinductive effect of polyphosphates. MATERIALS AND METHODS: Forty adult New Zealand white rabbits underwent monolevel lumbar fusions, and were divided into two groups according to the fusion beds: twenty each between the laminae (posterior fusion group, PF group) and between the transverse processes (posterolateral fusion group, PLF group). In ten of twenty rabbits in the PF group, 0.8gm of autogenous iliac bone was grafted onto the right sides of the laminae, which were used as a control group (C1), with 0.4gm autogenous bone immersed in polyphosphate solution in the left sides as an experimental group (E1). In the other ten, 0.8gm of autogenous bone was grafted onto the right sides (C2) and 0.8gm of tricalcium phosphate porous blocks containing polyphosphate in the left sides (E2). The other twenty rabbits of the PLF group were similarly divided into C1, E1, C2 and E2 groups by grafting the same amount of materials between the transverse processes. The animals were sacrificed at the 16th postoperative week and the fusions evaluated grossly, radiologically and histologically. Statistical differences between the groups (C1 vs. E1, C2 vs. E2 and E1 vs. E2) in each of the PF and PLF groups were compared by chi-square tests. RESULTS: The fusions were finally determined by the gross finding using manual palpation. In the PF group, bony fusions were obtained in 90, 80, 90 and 70% of the C1, E1, C2 and E2 groups, respectively. In the PLF group, these were 80, 70, 60 and 0% of the C1, E1, C2 and E2 groups, respectively. Statistical analysis revealed differences only between C2 and E2 (p=0.005), and between E1 and E2 (p=0.002) of the PLF group. Histologically, beta-tricalcium phosphate particles containing polyphosphate were transformed into the osteoid in some areas of the PLF-E2 group, although only fibrous unions were obtained grossly. CONCLUSIONS: It is suggested that the polyphosphate may have an osteoinductive effect, even though the osteoinductive potency was very week in this fusion model of the rabbit lumbar spine. Therefore, further explorations, such as the threshold and optimal concentrations of polyphosphate in vivo and the best carrier material of polyphosphate, should be performed to obtain the optimal conditions for fusion.
Adult
;
Animals
;
Bone Regeneration
;
Humans
;
Metabolism
;
Osteoblasts
;
Palpation
;
Polyphosphates
;
Rabbits
;
Spine*
;
Transplants
3.Comparison of Cell Proliferation between Chronic Ulcerative Colitisand Acute Self-limited Colitis.
Ki Jung YUN ; Hyung Ryun YOO ; Suck Chei CHLI ; Yong Ho NAH
Journal of the Korean Society of Coloproctology 1999;15(2):99-106
PURPOSE: The ulcerative colitis is a major chronic intestinal disease of unknown etiology affecting principally the rectum and left colon, and its incidence is markedly increasing in Korea. The main differential diagnosis of ulcerative colitis is an acute self-limited colitis. This study was performed to evaluate difference of cell kinetics between chronic ulcerative colitis and acute self-limited colitis. METHODS: The normal colon (n=25), acute self-limited colitis (n=25) and chronic ulcerative colitis (n=25) were investigated by using Ki-67 immunohistochemical staining for proliferation and TUNEL method for apoptosis. The Ki-67 labeling indices and TUNEL labeling indices were determined. RESULTS: The means of Ki-67 labeling indices in normal colon, acute self-limited colitis and chronic ulcerative colitis were 5.14 5.25%, 6.81 5.73%, 13.10 10.15%, respectively. And the means of TUNEL labeling indices in normal colon, acute self-limited colitis and chronic ulcerative colitis were 1.59 0.10%, 2.54 1.60%, 2.51 1.40%, respectively. CONCLUSIONS: The apoptosis is one of method of cell loss in both acute self-limited colitis and chronic ulcerative colitis. High proliferative activity of chronic ulcerative colitis may predispose to mutational events in colonic mucosa, therefore may be one of the increased cancer risk factors in chronic ulcerative colitis.
Apoptosis
;
Cell Proliferation*
;
Colitis*
;
Colitis, Ulcerative
;
Colon
;
Diagnosis, Differential
;
In Situ Nick-End Labeling
;
Incidence
;
Intestinal Diseases
;
Kinetics
;
Korea
;
Mucous Membrane
;
Rectum
;
Risk Factors
;
Ulcer*
4.Correlation between Squamous Papilloma and Human Papillomavirus in Esophagus.
Ki Jung YUN ; Hyung Bae MOON ; Suck Chei CHOI ; Yong Ho NAH
Korean Journal of Gastrointestinal Endoscopy 1998;18(6):805-810
BACKGROUND/AIMS: Esophageal squamous papillorma is a rare benign lesion. This lesion is generally asymptomatic and solitary. Resent studies reveal the presence of human papil- lomavirus in certain cases of esophageal squamous papilloma, and human papillomavirus appears to be pathogenetically related to the esophageal squamous papilloma. The aim of this study was to evaluate the presence of human papillomavirus in esoplmgeal spuamous papilloma. METHODS: In situ hybridizations and direct in situ polymerase chain reactions for human papillomavirus type 6/11 were performed on 16 paraffin embedded tissues with esophageal squamous papilloma. RESULTS: Human papillomavirus type 6/11 was detected in 1 of 16 esophageal squamous papillomas on direct in situ polymerase chain reaction. All lesions were solitary, and 12 of 16 cases were located in distal one-third of the esophagus. Age range was 23-71 years (mean, 41 years). CONCLUSION: These results indicate that causal relation between human papillomavirus type 6/11 and esophageal squamous papilloma is inconspicuous.
Esophagus*
;
Humans*
;
In Situ Hybridization
;
Papilloma*
;
Paraffin
;
Polymerase Chain Reaction
5.Results of Curative Radiotherapy Alone in Patients with Uterine Cervical Carcinomas.
Taek Keun NAM ; Byung Sik NAH ; Sung Ja AHN ; Woong Ki CHUNG ; Ho Seon CHOI ; Yoon Kyeong OH
Cancer Research and Treatment 2002;34(5):365-371
PURPOSE: To evaluate the role of curative radiotherapy alone in the treatment of uterine cervical carcinomas, by a retrospective analysis with respects to survival and pelvic control, and to find any risk factors of failure MATERIALS AND METHODS: Between Jan. 1990 and Dec. 1995, a total of 187 patients, diagnosed with uterine cervical carcinomas in FIGO stages greater than IA, were treated by curative radiotherapy alone with no chemotherapy. The ages of the patients ranged from 26 to 80 years, with a median of 60 years. The number of patients diagnosed with squamous cell carcinomas were 183 (97.9%). The number of patients with FIGO stage IB1, IB2, IIA, IIB, IIIA, IIIB and IVA were 61 (32.6%), 7 (3.7%), 43 (23.0%), 62 (33.3%), 3 (1.6%), 7 (3.7%) and 4 (2.1%), respectively. External radiotherapy was performed with 6 MV or 10 MV X-rays, with a dose range of 19.8 Gy~ 50.4 Gy (median; 30.6), to whole pelvis. Intracavitary radiation (ICR) was then performed using a high-dose rate remote controlled afterloader with radioisotopes of Co-60 and Cs-137. The fraction size of the ICR was 5 Gy twice a week, and was delivered up to total doses of 10 Gy~ 55 Gy (median; 40). After the ICR, additional pelvic external radiotherapy with midline shielding width of 4 cm was performed with the dose range of 0~30.6 Gy (median; 19.8), and the resultant total doses of A points ranged between 49.8 Gy and 86.0 Gy (median; 70.6). RESULTS: The five-year overall survival rates of FIGO IB1, IB2, IIA, IIB, III and IVA were 88.3%, 83.3%, 86.1%, 65.2%, 60.0% and 50.0%, respectively (p=0.005). The pelvic control rates of each stage were 90.1%, 85.7%, 86.1%, 69.4%, 68.6% and 50.0%, respectively (p=0.03). From the multivariate analysis, the radiation response and tumor diameter were found to be significant factors affecting the overall survival. The significant factors influencing pelvic control were the radiation response and pre-treatment hemoglobin level. CONCLUSION: The radiation response and tumor diameter were significant factors affecting survival, so patients with tumor diameters greater than 4 cm should be considered for a combined modality, such as concurrent chemoradiotherapy.
Carcinoma, Squamous Cell
;
Chemoradiotherapy
;
Drug Therapy
;
Humans
;
Multivariate Analysis
;
Pelvis
;
Radioisotopes
;
Radiotherapy*
;
Retrospective Studies
;
Risk Factors
;
Survival Rate
6.Irradiation alone in Stage IB , IIA and IIB Cervix Cancer: 2 Correlation between Treatment Factors and Pelvic Tumor Control.
Sung Ja AHN ; Woong Ki CHUNG ; Byung Sik NAH ; Taek Keun NAM ; Ho Sun CHOI ; Ji Soo BYUN
Journal of the Korean Cancer Association 1998;30(2):321-328
No abstract available.
Cervix Uteri*
;
Female
;
Uterine Cervical Neoplasms*
7.Results of Postoperative Irradiation in Patients with Carcinoma of Uterine Cervix Stage IB and IIA.
Sung Ja AHN ; Taek Keun NAM ; Woong Ki CHUNG ; Byung Sik NAH ; Ho Sun CHOI ; Ji Soo BYUN
Journal of the Korean Society for Therapeutic Radiology 1995;13(1):41-48
PURPOSE: The adjuvant postoperative radiotherapy has been usually applied to the patients with unfavorable prognostic factors after radical operation in early cervical cancer. We focused on the evaluation of the survival status and failure patterns of the patients with postoperative radiotherapy. MATERIALS AND METHODS: We retrospectively analyzed ninety patients with FIGO stage IB and IIA cervix cancer who received postoperative pelvic irradiation at Chonnam University Hospital between August 1985 and December 1988. Seventy-eight patients had adequate follow-up information for survival anlysis. Median follow-up time of these patients was 64 months. RESULTS: The 5 year overall and disease free survival rate of ninety patients was 80.0% and 80.2% respectively. The prognostic significance to the survival was determined by multivariate analysis. Adequacy of resection margin(p=0.005) and lymph node status(p=0.005) appeared to be independent prognostic factors. Recurrence occurred in 13 Patients, 5 in the pelvis and 8 at distant sites. He median time to recurrence was 19 months(range;3-39 months). The pelvic recurrence was more prevalent in the group of patients with adenocarcinoma, depth of stromal invasion more that 10mm and use of chemotherapy. The distant failure was more prevalent in the group of positive resection margin or positive lymph node with statistical significance. CONCLUSION: Patients with pelvic lymph node or surgical margin involvement clearly constitute a high risk group in this analysis and should be considered as candidates for some form of adjuvant therapy.
Adenocarcinoma
;
Cervix Uteri*
;
Disease-Free Survival
;
Drug Therapy
;
Female
;
Follow-Up Studies
;
Humans
;
Jeollanam-do
;
Lymph Nodes
;
Multivariate Analysis
;
Pelvis
;
Radiotherapy
;
Recurrence
;
Retrospective Studies
;
Uterine Cervical Neoplasms
8.Significance of p53 Immunoreactivity in Squamous Cell Carcinoma of the Cervix Treated with Radiotherapy Alone.
Sung Ja AHN ; Ho Sun CHOI ; Chan CHOI ; Byung Sik NAH ; Woong Ki CHUNG ; Taek Keun NAM
Journal of the Korean Cancer Association 2001;33(2):106-112
PURPOSE: We undertook this study to evaluate the significance of p53 immunoreactivity in squamous cell carcinoma of the cervix, treated with radiotherapy alone. MATERIALS AND METHODS: Immunohistochemical staining of p53 proteins were performed in eighty patients with squamous cell carcinoma of the cervix, and who completed curative radiotherapy between Jan. 1996 and Apr. 1998 at the Department of Therapeutic Radiology, Chonnam National University Hospital. External- beam radiotherapy was combined with intracavitary brachytherapy. Results were analyzed for the end points of pelvic tumor control and distant failure rates. The follow-up time ranged from 7 to 58 months with a median of 40 months. RESULTS: p53 positive and negative groups involved 45 and 35 patients, respectively, and the positive p53 immunoreactivity rate was 56% (45/80). p53 immunoreactivity showed no significant correlation with age, tumor size, serum tumor marker (SCC), or HPV18 expression, while there was a statistically marginally significant correlation with HPV16 expression. The pelvic tumor control rate of the p53 positive group was 87% and that of p53 negative group was 83% (0.05). The other parameters influencing negatively to the pelvic tumor control and with statistical significance were tumor ulceration and barrel type. Multivariate analysis also showed that p53 immunoreactivity had no prognostic value for pelvic tumor control of the disease, and that the statistically significant factor was tumor ulceration. The treatment failure rate of the p53 positive group was 23% and that of the negative group was 26% (p>0.05). CONCLUSION: p53 immunoreactivity in the cervix cancer stage IB, II patients seems to have no value as a predictor of tumor behavior after curative radiotherapy.
Brachytherapy
;
Carcinoma, Squamous Cell*
;
Cervix Uteri*
;
Female
;
Follow-Up Studies
;
Humans
;
Jeollanam-do
;
Multivariate Analysis
;
Radiation Oncology
;
Radiotherapy*
;
Treatment Failure
;
Ulcer
;
Uterine Cervical Neoplasms
9.Irradiation Alone in Stage IB, IIA, and IIB Cervix.
Sung Ja AHN ; Woong Ki CHUNG ; Byung Sik NAH ; Taek Keun NAM ; Ho Sun CHOI ; Ji Soo BYUN
Journal of the Korean Society for Therapeutic Radiology 1997;15(2):129-136
PURPOSE: We analyzed the survival and failure patterns of cervix cancer patients treated with irradiation alone to evaluate our treatment method and to compare with the others. METHODS AND MATERIALS: Two hundred and twenty cervical cancer patients, Stage IB, IIA, and IIB who completed the planned treatment between May 1987 and December 1991 were analyzed retrospectively. The Stage IB patients were restaged to the Stage IB1 and IB2 by the recently revised FIGO classification. Patients were treated with a combination of external irradiation and the intracavitary brachytherapy. Determination of the tumor control was done at the time of 6 months postirradiation. The follow-up time was ranged from 3 to 115 months and the mean was 62 months and the follow-up rate was 93.6%(206/220). RESULTS: The overall 5-year survival rate of Stage IB1(N=50), IB2(N=15), IIA(N=58), and IIB(N=97) was 94%, 87%, 69%, and 56%, respectively. In the univariate analysis of prognostic factors,stage(0.00), initial Hg level (p=0.00), initial TA-4(tumor-associated) antigen level(p=0.02), initial CEA level(p=0.02), barrel-shaped tumor(p=0.02), whole cervical involvement (0.00), pelvic lymphadenopathy(LAP) in CT(p=0.04), and post-irradiation adjuvant chemotherapy(p=0.00) were statistically significant in survival analysis. In a while, multivariate analysis showed that the stage was the most powerful prognostic indicator and the post-irradiation chemotherapy factor also showed the statistical significance. The overall local control rate was 81% and by the stage, 100% in Stage IB1, 86.7% in Stage IB2, 84.5% in Stage IIA, and 68.1% in Stage IIB, respectively. The overall tumor recurrence rate was 15.5%(27/174) and by the stage, 8%(4/50) in Stage IB1, 0%(0/13) in Stage IB2, 22.4%(11/49) in Stage IIA, and 19.4%(12/62) in Stage IIB, respectively. CONCLUSIONS: We obtained the similar treatment results to the other's ones in early stage cervical cancer patients. But in Stage IIB, the local control rate was lower than that of the other institutes and also the survival was poorer. So it seems to be necessary to reevaluate the treatment method in advanced cervical cancer patients.
Academies and Institutes
;
Brachytherapy
;
Cervix Uteri*
;
Classification
;
Drug Therapy
;
Female
;
Follow-Up Studies
;
Humans
;
Multivariate Analysis
;
Radiotherapy
;
Recurrence
;
Retrospective Studies
;
Survival Rate
;
Uterine Cervical Neoplasms
10.The Effect of Posterior Lumbar Interbody Fusion After Posterolateral Fusion in Degenerative Spondylolisthesis.
Ki Ho NAH ; Jae Hyuk SHIN ; Nam Yong CHOI ; Yong Sun LEE ; Kee Yong HA
The Journal of the Korean Orthopaedic Association 2005;40(7):852-860
PURPOSE: To determine the necessity of an additional posterior lumbar interbody fusion (PLIF) after a posterolateral fusion (PLF) for the treatment of degenerative spondylolisthesis (DS). MATERIALS AND METHODS: A retrospective study, after a minimum follow-up of 2 years was conducted on forty patients who underwent a single level decompression and instrumented fusion for DS with spinal stenosis at the L4-5 level. A PLF was performed in 21 patients, and a circumferential fusion (CF) with an additional PLIF in 19 patients. According to the fusion methods and preoperative segmental mobility, the patients were divided into four groups; s-PLF group (PLF in the stable group, n=13), s-PLIF group (CF in the stable group, n=11), u-PLF group (PLF in the unstable group, n=8), and u-PLIF group (CF in the unstable group, n=8). Clinical and radiographic comparisions between the PLF and PLIF groups were performed. RESULTS: The mean decrements of Oswestry Disability Index (Visual Analog Scale) scores were 29% (5.5), 29% (5.9), 22% (2.6) and 42% (5.9) respectively for the s-PLF, s-PLIF, u-PLF and u-PLIF groups, and a statistical difference was found only between the u-PLF and u-PLIF groups (ODI: p=0.032, VAS: p=0.004). Fusion rates were 92%, 100%, 88% and 100% respectively. The mean slip angle increments were serially 2.5 degrees, -3.1 degrees, -1.5 degrees and -0.3 degrees, and the mean percent slip decrements were 6.7%, 8.7%, 5.1% and 3.7%, and the mean disc height increments were -0.4 mm, 1.8 mm, 0.5 mm and 3.0 mm, and the mean lumbar lordosis increments were 8.6 degrees, 4.7 degrees, -1.9 degrees and 1.9 degrees and the mean sacral tilt increments were 3.8 degrees, 3.4 degrees, -1.3 degrees and 0.9 degrees. Statistical differences were found only between the s-PLF and s-PLIF groups in slip angle increments (p=0.029) and between the s-PLF and s-PLIF groups (p=0.043) and between the u-PLF and u-PLIF groups (p=0.042) in disc height increments. CONCLUSION: PLF alone provided successful clinical outcome in stable group, but CF provided better clinical outcomes in the unstable groups. This study suggests that preoperative segmental mobility may be a criterion to determine whether or not an additional PLIF is necessary in the treatment of lumbar DS.
Animals
;
Decompression
;
Follow-Up Studies
;
Humans
;
Lordosis
;
Retrospective Studies
;
Spinal Stenosis
;
Spondylolisthesis*